Clorox price target lowered to $134 from $139 at Barclays

Barclays lowered the firm’s price target on Clorox (CLX) to $134 from $139 and keeps an Underweight rating on the shares as part of a Q1 earnings preview for the consumer staples group. The consumer “malaise” was present well ahead of “Liberation Day,” and Barclays doubts the 90-day “period of limbo will breathe new life into these categories,” the analyst tells investors in a research note. The firm says that while tariff-related cost headwinds may have subsided, there remains a heightened period of uncertainty for consumer staples.